We have previously compared the combination of CCI-779 plus IFN-γ with single agent CCI-779 and single agent IFN-γ in nude mice bearing Tsc2-/- tumors and found a significant reduction in tumor growth and improved survival with combination therapy [11]. Here, TSC2 is linked to neoplasm.